These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 2844953)
1. Epstein-Barr virus regulates activation and processing of the third component of complement. Mold C; Bradt BM; Nemerow GR; Cooper NR J Exp Med; 1988 Sep; 168(3):949-69. PubMed ID: 2844953 [TBL] [Abstract][Full Text] [Related]
2. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1. Medof ME; Nussenzweig V J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387 [TBL] [Abstract][Full Text] [Related]
3. Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b. Seya T; Okada M; Nishino H; Atkinson JP J Biochem; 1990 Feb; 107(2):310-5. PubMed ID: 2141838 [TBL] [Abstract][Full Text] [Related]
4. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor. Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408 [TBL] [Abstract][Full Text] [Related]
5. Complement alternative pathway activation and control on membranes of human lymphoid B cell lines. Caudwell V; Porteu F; Calender A; Pangburn MK; Halbwachs-Mecarelli L Eur J Immunol; 1990 Dec; 20(12):2643-50. PubMed ID: 1702720 [TBL] [Abstract][Full Text] [Related]
6. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. Sahu A; Isaacs SN; Soulika AM; Lambris JD J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165 [TBL] [Abstract][Full Text] [Related]
7. Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46). Masaki T; Matsumoto M; Nakanishi I; Yasuda R; Seya T J Biochem; 1992 May; 111(5):573-8. PubMed ID: 1386357 [TBL] [Abstract][Full Text] [Related]
8. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794 [TBL] [Abstract][Full Text] [Related]
9. Structural and functional studies on the human C3b/C4b receptor (CR1) purified by affinity chromatography using a monoclonal antibody. Holers VM; Seya T; Brown E; O'Shea JJ; Atkinson JP Complement; 1986; 3(2):63-78. PubMed ID: 2945695 [TBL] [Abstract][Full Text] [Related]
10. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1). Kinoshita T; Lavoie S; Nussenzweig V J Immunol; 1985 Apr; 134(4):2564-70. PubMed ID: 3156184 [TBL] [Abstract][Full Text] [Related]
11. Membrane-bound C4b interacts endogenously with complement receptor CR1 of human red cells. Kinoshita T; Medof ME; Hong K; Nussenzweig V J Exp Med; 1986 Nov; 164(5):1377-88. PubMed ID: 2430040 [TBL] [Abstract][Full Text] [Related]
12. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases. Pangburn MK J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425 [TBL] [Abstract][Full Text] [Related]
13. Modulation of neutrophil expression of C3b receptors (CR1) by soluble monomeric human C3b. Porteu F; Mir A; Halbwachs-Mecarelli L Eur J Immunol; 1987 May; 17(5):629-35. PubMed ID: 2953614 [TBL] [Abstract][Full Text] [Related]
14. Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component. Lambris JD; Lao Z; Oglesby TJ; Atkinson JP; Hack CE; Becherer JD J Immunol; 1996 Jun; 156(12):4821-32. PubMed ID: 8648130 [TBL] [Abstract][Full Text] [Related]
15. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF). Seya T; Holers VM; Atkinson JP J Immunol; 1985 Oct; 135(4):2661-7. PubMed ID: 3161944 [TBL] [Abstract][Full Text] [Related]
16. Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b. Tse PK; Lee YL; Chow WN; Luk JM; Lee KF; Yeung WS Endocrinology; 2008 Mar; 149(3):1268-76. PubMed ID: 18039777 [TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1. Nilsson-Ekdahl K; Nilsson B Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329 [TBL] [Abstract][Full Text] [Related]
18. Complement receptor is an inhibitor of the complement cascade. Iida K; Nussenzweig V J Exp Med; 1981 May; 153(5):1138-50. PubMed ID: 6910481 [TBL] [Abstract][Full Text] [Related]
19. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3. Newman SL; Mikus LK J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200 [TBL] [Abstract][Full Text] [Related]
20. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules. Medicus RG; Melamed J; Arnaout MA Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]